Sequential changes in bone biochemical parameters and bone mineral density after renal transplant

Area of Science:

• Nephrology
• Endocrinology
• Bone Metabolism

Background:

• Renal transplantation significantly alters mineral and bone metabolism.
• Post-transplant bone health is crucial for long-term patient outcomes.

Purpose of the Study:

• To track biochemical bone markers, parathyroid hormone (iPTH), vitamin D, and bone mineral density (BMD) for 24 weeks post-renal transplant.
• Identify changes and risk factors for bone health complications after transplantation.

Main Methods:

• Prospective study of 75 first-time renal transplant recipients.
• Biochemical parameters (calcium, phosphorus, albumin, iPTH, vitamin D) and BMD measured at baseline and various intervals up to 24 weeks post-transplant.

Main Results:

• Significant early fall and subsequent rise in serum calcium, with hypercalcemia in 8% at 24 weeks.
• 25% of patients developed hypophosphatemia by 24 weeks.
• iPTH levels declined but persistent hyperparathyroidism (HPT) affected over 50% at 24 weeks.
• BMD decreased by 2.7%, correlated with pre-transplant iPTH; tacrolimus use was associated with less BMD decline.

Conclusions:

• Hypercalcemia, hypophosphatemia, persistent HPT, and BMD decline are common after renal transplantation.
• Elevated baseline iPTH, graft dysfunction, and low vitamin D are risk factors for HPT.
• Tacrolimus may offer some protection against BMD loss.